GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Total Equity

Cytogen (XKRX:217330) Total Equity : ₩57,085 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cytogen Total Equity?

Cytogen's total equity for the quarter that ended in Mar. 2024 was ₩57,085 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cytogen Total Equity Historical Data

The historical data trend for Cytogen's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytogen Total Equity Chart

Cytogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,920.04 18,336.92 23,008.99 5,656.22 53,355.39

Cytogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,031.76 7,635.21 10,214.94 53,355.39 57,084.81

Cytogen Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cytogen's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=74450.07-21094.677
=53,355

Cytogen's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=77617.443-20532.638
=57,085

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytogen Total Equity Related Terms

Thank you for viewing the detailed overview of Cytogen's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytogen (XKRX:217330) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Total Equity
Comparable Companies
XKRX:084650 XKRX:384470 XKRX:950130 XKRX:180400 XKRX:038290 XKRX:376930 XKRX:051980 XKRX:153710 XKRX:950200 XKRX:363250 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
128, Beobwon-ro, Songpa-gu, A-8 Floor, SK V1 GL Metrocity, Seoul, KOR, 05854
Website
http://www.cytogenlab.com
Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

Cytogen (XKRX:217330) Headlines

No Headlines